An intervention to improve teacher well-being support and training to support students in UK high schools (the WISE study): A cluster randomised controlled trial.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
03
05
2021
accepted:
12
10
2021
revised:
29
11
2021
pubmed:
12
11
2021
medline:
22
12
2021
entrez:
11
11
2021
Statut:
epublish
Résumé
Teachers are at heightened risk of poor mental health and well-being, which is likely to impact on the support they provide to students, and student outcomes. We conducted a cluster randomised controlled trial, to test whether an intervention to improve mental health support and training for high school teachers led to improved mental health and well-being for teachers and students, compared to usual practice. We also conducted a cost evaluation of the intervention. The intervention comprised (i) Mental Health First Aid training for teachers to support students; (ii) a mental health awareness session; and (iii) a confidential staff peer support service. In total 25 mainstream, non-fee-paying secondary schools stratified by geographical area and free school meal entitlement were randomly allocated to intervention (n = 12) or control group (n = 13) after collection of baseline measures. We analysed data using mixed-effects repeated measures models in the intention-to-treat population, adjusted for stratification variables, sex, and years of experience. The primary outcome was teacher well-being (Warwick-Edinburgh Mental Well-being Scale). Secondary outcomes were teacher depression, absence, and presenteeism, and student well-being, mental health difficulties, attendance, and attainment. Follow-up was at months 12 (T1) and 24 (T2). We collected process data to test the logic model underpinning the intervention, to aid interpretation of the findings. A total of 1,722 teachers were included in the primary analysis. Teacher well-being did not differ between groups at T2 (intervention mean well-being score 47.5, control group mean well-being score 48.4, adjusted mean difference -0.90, 95% CI -2.07 to 0.27, p = 0.130). The only effect on secondary outcomes was higher teacher-reported absence among the intervention group at T2 (intervention group median number of days absent 0, control group median number of days absent 0, ratio of geometric means 1.04, 95% CI 1.00 to 1.09, p = 0.042). Process measures indicated little change in perceived mental health support, quality of relationships, and work-related stress. The average cost of the intervention was £9,103 per school. The study's main limitations were a lack of blinding of research participants and the self-report nature of the outcome measures. In this study, we observed no improvements to teacher or student mental health following the intervention, possibly due to a lack of impact on key drivers of poor mental health within the school environment. Future research should focus on structural and cultural changes to the school environment, which may be more effective at improving teacher and student mental health and well-being. www.isrctn.com ISRCTN95909211.
Sections du résumé
BACKGROUND
Teachers are at heightened risk of poor mental health and well-being, which is likely to impact on the support they provide to students, and student outcomes. We conducted a cluster randomised controlled trial, to test whether an intervention to improve mental health support and training for high school teachers led to improved mental health and well-being for teachers and students, compared to usual practice. We also conducted a cost evaluation of the intervention.
METHODS AND FINDINGS
The intervention comprised (i) Mental Health First Aid training for teachers to support students; (ii) a mental health awareness session; and (iii) a confidential staff peer support service. In total 25 mainstream, non-fee-paying secondary schools stratified by geographical area and free school meal entitlement were randomly allocated to intervention (n = 12) or control group (n = 13) after collection of baseline measures. We analysed data using mixed-effects repeated measures models in the intention-to-treat population, adjusted for stratification variables, sex, and years of experience. The primary outcome was teacher well-being (Warwick-Edinburgh Mental Well-being Scale). Secondary outcomes were teacher depression, absence, and presenteeism, and student well-being, mental health difficulties, attendance, and attainment. Follow-up was at months 12 (T1) and 24 (T2). We collected process data to test the logic model underpinning the intervention, to aid interpretation of the findings. A total of 1,722 teachers were included in the primary analysis. Teacher well-being did not differ between groups at T2 (intervention mean well-being score 47.5, control group mean well-being score 48.4, adjusted mean difference -0.90, 95% CI -2.07 to 0.27, p = 0.130). The only effect on secondary outcomes was higher teacher-reported absence among the intervention group at T2 (intervention group median number of days absent 0, control group median number of days absent 0, ratio of geometric means 1.04, 95% CI 1.00 to 1.09, p = 0.042). Process measures indicated little change in perceived mental health support, quality of relationships, and work-related stress. The average cost of the intervention was £9,103 per school. The study's main limitations were a lack of blinding of research participants and the self-report nature of the outcome measures.
CONCLUSIONS
In this study, we observed no improvements to teacher or student mental health following the intervention, possibly due to a lack of impact on key drivers of poor mental health within the school environment. Future research should focus on structural and cultural changes to the school environment, which may be more effective at improving teacher and student mental health and well-being.
TRIAL REGISTRATION
www.isrctn.com ISRCTN95909211.
Identifiants
pubmed: 34762673
doi: 10.1371/journal.pmed.1003847
pii: PMEDICINE-D-21-02018
pmc: PMC8629387
doi:
Banques de données
ISRCTN
['ISRCTN95909211']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003847Subventions
Organisme : Department of Health
ID : 13/164/06
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K023233/1
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Health Soc Behav. 2011 Jun;52(2):145-61
pubmed: 21673143
J R Soc Med. 2011 May;104(5):198-207
pubmed: 21558098
BMC Psychiatry. 2004 Aug 15;4:23
pubmed: 15310395
BMC Psychiatry. 2010 Jun 24;10:51
pubmed: 20576158
Trials. 2020 Aug 26;21(1):745
pubmed: 32847622
J Affect Disord. 2016 Mar 1;192:76-82
pubmed: 26707351
BMC Public Health. 2016 Oct 6;16(1):1060
pubmed: 27716226
Lancet. 2018 Dec 8;392(10163):2452-2464
pubmed: 30473366
BMC Public Health. 2016 Oct 18;16(1):1089
pubmed: 27756268
Am J Health Promot. 2013 Sep-Oct;28(1):TAHP2-10
pubmed: 24137807
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
J Sch Psychol. 2015 Oct;53(5):337-57
pubmed: 26407833
Lancet Psychiatry. 2019 Dec;6(12):1011-1020
pubmed: 31734106
Int J Ment Health Syst. 2011 Jan 27;5(1):4
pubmed: 21272345
Qual Saf Health Care. 2008 Aug;17(4):249-52
pubmed: 18678720
Br J Psychiatry. 2013 May;202(5):336-41
pubmed: 23637109
J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1337-45
pubmed: 11699809
J Affect Disord. 2019 Jan 1;242:180-187
pubmed: 30189355
Pediatrics. 2012 May;129(5):925-49
pubmed: 22473374
Cochrane Database Syst Rev. 2015 Apr 08;(4):CD010306
pubmed: 25851427
BMC Public Health. 2011 Jun 21;11:487
pubmed: 21693055
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
BMC Public Health. 2014 Jun 11;14:588
pubmed: 24916716
BMJ. 2011 Feb 07;342:d40
pubmed: 21300711
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
Psychol Med. 2019 Apr;49(5):828-842
pubmed: 30017006
Int Rev Psychiatry. 2014 Aug;26(4):467-75
pubmed: 25137113
Clin Trials. 2014 Feb;11(1):28-37
pubmed: 24096636
BMC Public Health. 2021 Jan 23;21(1):207
pubmed: 33485308
Trials. 2018 May 4;19(1):270
pubmed: 29728149